Tam Kevin J, Dalal Kush, Hsing Michael, Cheng Chi Wing, Khosravi Shahram, Yenki Parvin, Tse Charan, Peacock James W, Sharma Aishwariya, Chiang Yan Ting, Wang Yuzhuo, Cherkasov Artem, Rennie Paul S, Gleave Martin E, Ong Christopher J
Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC, Canada.
Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
Oncotarget. 2017 Feb 7;8(6):9617-9633. doi: 10.18632/oncotarget.14168.
The androgen receptor (AR) is a member of the nuclear receptor superfamily of transcription factors and is central to prostate cancer (PCa) progression. Ligand-activated AR engages androgen response elements (AREs) at androgen-responsive genes to drive the expression of gene batteries involved in cell proliferation and cell fate. Understanding the transcriptional targets of the AR has become critical in apprehending the mechanisms driving treatment-resistant stages of PCa. Although AR transcription regulation has been extensively studied, the signaling networks downstream of AR are incompletely described. Semaphorin 3C (SEMA3C) is a secreted signaling protein with roles in nervous system and cardiac development but can also drive cellular growth and invasive characteristics in multiple cancers including PCa. Despite numerous findings that implicate SEMA3C in cancer progression, regulatory mechanisms governing its expression remain largely unknown. Here we identify and characterize an androgen response element within the SEMA3C locus. Using the AR-positive LNCaP PCa cell line, we show that SEMA3C expression is driven by AR through this element and that AR-mediated expression of SEMA3C is dependent on the transcription factor GATA2. SEMA3C has been shown to promote cellular growth in certain cell types so implicit to our findings is the discovery of direct regulation of a growth factor by AR. We also show that FOXA1 is a negative regulator of SEMA3C. These findings identify SEMA3C as a novel target of AR, GATA2, and FOXA1 and expand our understanding of semaphorin signaling and cancer biology.
雄激素受体(AR)是转录因子核受体超家族的成员,对前列腺癌(PCa)的进展至关重要。配体激活的AR与雄激素反应基因上的雄激素反应元件(AREs)结合,以驱动参与细胞增殖和细胞命运的基因簇的表达。了解AR的转录靶点对于理解驱动PCa治疗抵抗阶段的机制至关重要。尽管对AR转录调控进行了广泛研究,但AR下游的信号网络仍未完全阐明。信号素3C(SEMA3C)是一种分泌型信号蛋白,在神经系统和心脏发育中发挥作用,但也可在包括PCa在内的多种癌症中驱动细胞生长和侵袭特性。尽管有许多研究发现SEMA3C与癌症进展有关,但其表达的调控机制仍 largely未知。在这里,我们鉴定并表征了SEMA3C基因座内的一个雄激素反应元件。使用AR阳性的LNCaP前列腺癌细胞系,我们表明SEMA3C的表达是由AR通过该元件驱动的,并且AR介导的SEMA3C表达依赖于转录因子GATA2。SEMA3C已被证明在某些细胞类型中促进细胞生长,因此我们的发现暗示了AR对生长因子的直接调控。我们还表明FOXA1是SEMA3C 的负调节因子。这些发现确定SEMA3C为AR, GATA2和FOXA1的新靶点,并扩展了我们对信号素信号传导和癌症生物学的理解。